{"title":"GLP-1减肥方案:一个基于证据的翻译项目。","authors":"Meghan Allred","doi":"10.1891/JDNP-2024-0021","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Obesity is a prevalent chronic disease associated with many comorbidities and increased mortality rates. Primary care providers are critical in addressing obesity through an evidence-based weight loss protocol. <b>Objective:</b> This Doctor of Nurse Practice project aimed to develop and implement a standardized, evidence-based holistic weight loss protocol, incorporating glucagon-like peptide-1 (GLP-1) medication, semaglutide, and motivational interviewing within a patient-centered framework. <b>Methods:</b> In this quality improvement project, 10 nondiabetic participants with a body mass index (BMI) ≥ 27 kg/m² were recruited from a suburban clinic in Cypress, TX. Data such as body weight, BMI, and blood pressure were collected in addition to Impact of Weight on Quality of Life-Lite (IWQOL-lite) survey responses. Data were then analyzed in Excel using the paired <i>t</i> test with statistical significance being <.05. <b>Results:</b> Participants lost a significant amount of weight (<i>p</i> < .05) and had a significant decrease in BMI (<i>p</i> < .05). Postintervention physical function, self-esteem, and work-related experiences improved significantly (<i>p</i> < .05) based on the IWQOL questionnaire pre- and postintervention. Diastolic blood pressure also significantly decreased (<i>p</i> < .05). <b>Conclusions:</b> This weight loss protocol, guided by evidence-based practice alongside GLP-1 medication, semaglutide, revealed positive outcomes in weight reduction, BMI, and quality of life. This protocol offers providers a promising approach to managing obesity in primary care settings. <b>Implications for Nursing:</b> Implementing this evidence-based weight loss protocol can empower advanced practice nurses (APRNs) to address obesity effectively. Motivational interviewing, holistic patient-centered care, ongoing support, and education are critical features to sustaining weight loss for obese patients. This protocol provides a structured approach for APRNs in guiding nondiabetic overweight and obese patients toward sustainable weight loss.</p>","PeriodicalId":40310,"journal":{"name":"Journal of Doctoral Nursing Practice","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GLP-1 Weight Loss Protocol: An Evidence-Based Translation Project.\",\"authors\":\"Meghan Allred\",\"doi\":\"10.1891/JDNP-2024-0021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Obesity is a prevalent chronic disease associated with many comorbidities and increased mortality rates. Primary care providers are critical in addressing obesity through an evidence-based weight loss protocol. <b>Objective:</b> This Doctor of Nurse Practice project aimed to develop and implement a standardized, evidence-based holistic weight loss protocol, incorporating glucagon-like peptide-1 (GLP-1) medication, semaglutide, and motivational interviewing within a patient-centered framework. <b>Methods:</b> In this quality improvement project, 10 nondiabetic participants with a body mass index (BMI) ≥ 27 kg/m² were recruited from a suburban clinic in Cypress, TX. Data such as body weight, BMI, and blood pressure were collected in addition to Impact of Weight on Quality of Life-Lite (IWQOL-lite) survey responses. Data were then analyzed in Excel using the paired <i>t</i> test with statistical significance being <.05. <b>Results:</b> Participants lost a significant amount of weight (<i>p</i> < .05) and had a significant decrease in BMI (<i>p</i> < .05). Postintervention physical function, self-esteem, and work-related experiences improved significantly (<i>p</i> < .05) based on the IWQOL questionnaire pre- and postintervention. Diastolic blood pressure also significantly decreased (<i>p</i> < .05). <b>Conclusions:</b> This weight loss protocol, guided by evidence-based practice alongside GLP-1 medication, semaglutide, revealed positive outcomes in weight reduction, BMI, and quality of life. This protocol offers providers a promising approach to managing obesity in primary care settings. <b>Implications for Nursing:</b> Implementing this evidence-based weight loss protocol can empower advanced practice nurses (APRNs) to address obesity effectively. Motivational interviewing, holistic patient-centered care, ongoing support, and education are critical features to sustaining weight loss for obese patients. This protocol provides a structured approach for APRNs in guiding nondiabetic overweight and obese patients toward sustainable weight loss.</p>\",\"PeriodicalId\":40310,\"journal\":{\"name\":\"Journal of Doctoral Nursing Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2025-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Doctoral Nursing Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1891/JDNP-2024-0021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NURSING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Doctoral Nursing Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1891/JDNP-2024-0021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NURSING","Score":null,"Total":0}
GLP-1 Weight Loss Protocol: An Evidence-Based Translation Project.
Background: Obesity is a prevalent chronic disease associated with many comorbidities and increased mortality rates. Primary care providers are critical in addressing obesity through an evidence-based weight loss protocol. Objective: This Doctor of Nurse Practice project aimed to develop and implement a standardized, evidence-based holistic weight loss protocol, incorporating glucagon-like peptide-1 (GLP-1) medication, semaglutide, and motivational interviewing within a patient-centered framework. Methods: In this quality improvement project, 10 nondiabetic participants with a body mass index (BMI) ≥ 27 kg/m² were recruited from a suburban clinic in Cypress, TX. Data such as body weight, BMI, and blood pressure were collected in addition to Impact of Weight on Quality of Life-Lite (IWQOL-lite) survey responses. Data were then analyzed in Excel using the paired t test with statistical significance being <.05. Results: Participants lost a significant amount of weight (p < .05) and had a significant decrease in BMI (p < .05). Postintervention physical function, self-esteem, and work-related experiences improved significantly (p < .05) based on the IWQOL questionnaire pre- and postintervention. Diastolic blood pressure also significantly decreased (p < .05). Conclusions: This weight loss protocol, guided by evidence-based practice alongside GLP-1 medication, semaglutide, revealed positive outcomes in weight reduction, BMI, and quality of life. This protocol offers providers a promising approach to managing obesity in primary care settings. Implications for Nursing: Implementing this evidence-based weight loss protocol can empower advanced practice nurses (APRNs) to address obesity effectively. Motivational interviewing, holistic patient-centered care, ongoing support, and education are critical features to sustaining weight loss for obese patients. This protocol provides a structured approach for APRNs in guiding nondiabetic overweight and obese patients toward sustainable weight loss.